Exopharm Webinar May 2020 – Our Strategic Response
to COVID-19
Exopharm updates the public on its recent progress and activities. Hosted by Jason Watson, Chair of Exopharm, Ian Dixon (CEO), Gregor Lichtfuss (COO) and Chris Baldwin (CCO) discuss how COVID-19 has affected operations and strategies.
The application of Exopharm’s engineered exosome program, Fortrexo, is discussed, including plans to add the SARS-CoV spike to the surface of EVs specifically designed to deliver RNAi to at-risk cells and defeat viruses at their own game.
Leave a Reply